Humanwell Healthcare | Briefing, News, Analysis, Research, Data

Humanwell Healthcare

Humanwell Healthcare insists on R&D as the guide

Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Mar 30, 1993

HQ location

Hubei, China

Legal name

Humanwell Healthcare (Group) Co., Ltd.

Website

http://www.renfu.com.cn/

renfu.pr@renfu.com.cn

Employees

10001-50000

All
News
Analysis
Research

Briefing Apr 25, 2022 04:05 PM · Consumer Staples | Technology | Healthcare

Nissan announced the progress of assisted driving technology, which can detect the deceleration traffic flow

Briefing Mar 10, 2022 03:59 PM · Technology | Healthcare | Consumer Staples

Meierya: elect Zheng Jiping as chairman and Duan Wenyan as general manager

In-depth

Healthcare

EqualOcean Sector Quarterly Report - Healthcare Sectors

To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.

Apr 07, 2022 01:44 PM

Briefing Mar 09, 2022 04:49 PM · Consumer Staples | Technology | Consumer Discretionary

Beijing: it is preliminarily believed that the source of infection of infected person 2 notified on the 8th is from other provinces

Briefing Feb 22, 2022 05:09 PM · Healthcare | Financials | Automotive

Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Research

Technology, Healthcare, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Technology, Consumer Staples, Real Estate

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Briefing Feb 14, 2022 05:00 PM · Technology | Healthcare | Communication

Optical cable: it is proposed to set up Jiangsu Tong Optoelectronics Technology, which is mainly engaged in raw material trade

Briefing Jan 21, 2022 06:09 PM · Technology | Healthcare

Zhangyu A: Sun Jian, director and general manager, increased 30000 B shares on January 21

Briefing Jan 05, 2022 03:49 PM · Consumer Staples | Technology | Healthcare

China Merchants Steamship: Directors and senior executives plan to reduce their total holdings of no more than 904200 shares

Briefing Jan 04, 2022 04:29 PM · Consumer Staples | Technology | Healthcare

Riyue Co., Ltd. "construction project of finishing production line for key components of large offshore wind power with an annual output of 120000 tons" is planned to be postponed

Healthcare

R&D of Anti-COVID-19 Drugs is Blooming in China

Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.

Updated 1 hour ago

Healthcare, Financials

Starna Therapeutics Nets CNY 150 Mn in Series A Financing Round

This is the second financing round of Starne Therapeutics, the mRNA drug developer founded in 2021, after its angel round of financing in December, 2021.

Yesterday 12:44 PM

Briefing Dec 06, 2021 03:39 PM · Technology | Healthcare

Hengrui medicine: a number of drugs have been approved to carry out clinical trials

Briefing Dec 03, 2021 03:59 PM · Consumer Staples | Technology | Healthcare

Alex: vometinib mesylate tablets are newly included in the national medical insurance catalogue

Briefing Nov 19, 2021 03:49 PM · Consumer Staples | Technology | Healthcare

Humanwell pharmaceutical: it is proposed to transfer 2.52% shares of Huatai Insurance with RMB 1.026 billion

Healthcare

Anti-Cancer Drug Developer Innovo Therapeutics Raises Nearly CNY 100 Mn in Angel Round

Targeted Protein Degradation (TPD) has developed rapidly in recent years, representing an unprecedented opportunity of new drug research and development.

May 15, 2022 11:05 PM

Healthcare

Drug Developer Greatsun Completes Series A Funding Worth Tens of Mns of CNY

Founded in 2011, Greatsun is an innovative drug R&D biotech in China. The company develops active targeting drug delivery nanocarriers and biological macromolecular drugs.

May 12, 2022 11:04 PM

Briefing Oct 18, 2021 01:06 AM · Consumer Staples | Financials

Three quarterly countdown institutions reward the bank sector configuration value

Briefing Oct 08, 2021 03:52 PM · Consumer Discretionary | Healthcare | Industrials

Daqin Railway: in September, the freight volume of Daqin Railway decreased by 1.45% year-on-year

Briefing Sep 27, 2021 03:49 PM · Technology | Healthcare | Financials

West Gate: normal production and stable operation have been restored recently

Briefing Sep 17, 2021 03:50 PM · Technology | Healthcare

Xiangjiang Holdings: it plans to repurchase shares with no more than 145 million yuan

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York Suite 2967, 29th Floor, 4 World Trade 150 Greenwich St, New York, NY 10006

About